Oxford Medical Simulation Secures New Funding

Oxford Medical Simulation, a London-based company specializing in AI-driven virtual reality (VR) healthcare training, has announced the successful closure of a €5.78 million growth funding round. The funding was led by Salica Investments, a firm known for supporting high-growth companies across Europe.

Founded in 2017 by Michael Wallace, who serves as CEO, Oxford Medical Simulation aims to elevate the quality of healthcare training by providing immersive, realistic clinical scenarios. Their platform empowers both learners and educators to improve health outcomes by preparing clinicians for real-world practice through VR simulations.

Strategic Expansion and Technological Advancements

The new funding will be primarily used to expand Oxford Medical Simulation's presence in the United States, targeting both health systems and academic institutions. "This financing allows us to invest confidently in the next phase of OMS," said CEO Michael Wallace. "Our partners in US healthcare and academia are focused on outcomes – safer practice, better-prepared staff, and more efficient delivery."

Use of Funds

  • Geographic Expansion: A significant portion of the funds will support the company's efforts to establish a stronger foothold in the U.S. market.
  • Platform Development: The investment will accelerate the development of their platform, including the creation of AI-driven clinical scenarios and enhanced learning analytics.
  • Infrastructure Improvements: The company plans to enhance its infrastructure to ensure effective delivery of clinical training at scale.

Meeting Critical Training Needs

Oxford Medical Simulation's platform is designed to bridge the gap between medical education and real-world clinical performance. By offering repeatable training simulations accessible anytime and anywhere, the company aims to improve clinical readiness and standardize training outcomes. This approach is particularly timely given the ongoing staffing challenges in the healthcare sector.

Salica Investments highlighted the importance of Oxford Medical Simulation’s platform in addressing critical training needs in healthcare and education. This growth capital will enable the company to expand its global footprint and refine its technology offerings, as demand for scalable and effective clinical training solutions continues to rise.

With this new funding, Oxford Medical Simulation is well-positioned to enhance its offerings and broaden its impact on healthcare training worldwide.